EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardioprotection and Suppression of Fibrosis by Diverse Cancer and Non-Cancer Cell Lines in a Murine Model of Duchenne Muscular Dystrophy

Laris Achlaug, Irina Langier Goncalves, Ami Aronheim iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25084273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Laris Achlaug und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Cancer Science, Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, P.O. Box 9649, …. Hauptthemen laut MEDLINE: Fibrosis, Muscular Dystrophy, Duchenne, Disease Models, Animal, Mice, Inbred mdx. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of health Israel, Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dynamic relationship between heart failure and cancer poses a dual challenge. While cardiac remodeling can promote cancer growth and metastasis, tumor development can ameliorate cardiac dysfunction and suppress fibrosis. However, the precise mechanism through which cancer influences the heart and fibrosis is yet to be uncovered. To further explore the interaction between heart failure and cancer, we used the MDX mouse model, which suffers from cardiac fibrosis and cardiac dysfunction. A previous study from our lab demonstrated that tumor growth improves cardiac dysfunction and dampens fibrosis in the heart and diaphragm muscles of MDX mice. We used breast Polyoma middle T (PyMT) and Lewis lung carcinoma (LLC) cancer cell lines that developed into large tumors. To explore whether the aggressiveness of the cancer cell line is crucial for the beneficial phenotype, we employed a PyMT breast cancer cell line lacking integrin β1, representing a less aggressive cell line compared to the original PyMT cells. In addition, we examined immortalized and primary MEF cells. The injection of integrin β1 KO PyMT cancer cells and Mouse Embryo Fibroblasts cells (MEF) resulted in the improvement of cardiac function and decreased fibrosis in the heart, diaphragm, and skeletal muscles of MDX mice. Collectively, our data demonstrate that the cancer line aggressiveness as well as primary MEF cells are sufficient to impose the beneficial phenotype. These discoveries present potential novel clinical therapeutic approaches with beneficial outcome for patients with fibrotic diseases and cardiac dysfunction that do not require tumor growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosisMuscular Dystrophy, DuchenneDisease Models, AnimalMice, Inbred mdxAnimalsMiceCell Line, TumorMice, Inbred C57BLFemaleMyocardiumIntegrin beta1FibroblastsHumans

Stichwörter der Autor:innen

Duchenne muscular dystrophycardiac dysfunctioncardiac remodelingfibrosis

Substanzen

Integrin beta1

Autor:innen und Institutionen

  • Department of Cell Biology and Cancer Science, Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, P.O. Box 9649, Haifa 31096, Israel.

ORCID-Profile: Ami Aronheim

Förderung

  • Ministry of health Israel
  • Ministry of Health

Zitieren

APA

Achlaug, L., Langier Goncalves, I., & Aronheim, A. (2024). Cardioprotection and Suppression of Fibrosis by Diverse Cancer and Non-Cancer Cell Lines in a Murine Model of Duchenne Muscular Dystrophy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25084273

Vancouver

Achlaug L, Langier Goncalves I, Aronheim A. Cardioprotection and Suppression of Fibrosis by Diverse Cancer and Non-Cancer Cell Lines in a Murine Model of Duchenne Muscular Dystrophy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25084273

BibTeX
@article{Achlaug2024,
  author = {Achlaug, Laris and Langier Goncalves, Irina and Aronheim, Ami},
  title = {Cardioprotection and Suppression of Fibrosis by Diverse Cancer and Non-Cancer Cell Lines in a Murine Model of Duchenne Muscular Dystrophy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25084273}
}
Kostenlos starten →